Beyond glucose lowering: Glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system
Year: 2011
Type: review
Source: Diabetes & Metabolism
Authors: B. Vergès, C. Bonnard, E. Renard
Institutions: Inserm, CHU Dijon Bourgogne, Hôpital Lapeyronie
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W2004932692